Blood clot prevention in abdominal or pelvic surgery
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether a medication called apixaban (a blood thinner) can safely prevent blood clots after abdominal or pelvic surgery. It is for people who have a moderate risk of clots and bleeding, and who are not taking other blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are planning to have elective abdominal or pelvic surgery (not emergency) that is at similar (not high) risk for blood clots or bleeding
- You have not had any active bleeding in the last 6 months that is not expected to be treated by the surgery
- You have not taken blood thinners (like apixaban, warfarin, aspirin, or omega-3 supplements) in the 7 days before surgery, and you do not expect to need them for 30 days after surgery
- You have not had chemotherapy, radiation, or hormone therapy for cancer in the last 6 months, and you do not expect to need it within 30 days after surgery
- You do not have a known bleeding disorder, liver or kidney problems, or a history of blood clots
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This trial tests whether giving medicine to prevent blood clots during varicose vein treatment is safe and helpful. It focuses on people having a minimally invasive procedure on enlarged leg veins under local anesthesia.
This trial tests whether apixaban, a blood thinner, can prevent dangerous blood clots in people with a certain type of malignant brain tumor who are getting radiation and chemotherapy. It may help lower the risk of clots like leg clots or lung clots.
This trial tests whether taking a blood thinner pill for 30 days after spine surgery helps prevent dangerous blood clots. It may help people recovering from surgery for cancer that has spread to the spine.
This study tests if the blood thinner apixaban is safe and effective for cancer patients who have low platelets and a recent blood clot. It may offer a treatment option for those who cannot take standard blood thinners.
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.